Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis? (Q46750518)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis? (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

infective endocarditis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

David Armstrong

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Stephen Wright

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Claire McVeigh

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Michael Finch

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

25

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

583-584

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Prevalence of infective endocarditis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10067-005-0031-2

21 January 2018

Cardiac abnormalities in SLE: pancarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically significant valvular heart disease in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16222410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-005-0031-2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16222410

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46750518&oldid=1641113624"